WO2010062396A3
(en )
2010-12-09
Virus like particle compositions and methods of use
WO2009036175A3
(en )
2009-05-07
F1f0-atpase inhibitors and related methods
WO2006119295A3
(en )
2007-03-15
Compositions and methods for the treatment of neurodegenerative diseases
WO2007095638A3
(en )
2008-07-31
Boron-containing small molecules as anti-inflammatory agents
HRP20130357T1
(en )
2013-05-31
Novel compounds useful for the treatment of degenerative and inflammatory diseases.
AU2016219704A1
(en )
2016-09-15
Anti-Notch1 antibodies
MX2009006536A
(en )
2009-06-26
Organic compounds and their uses.
WO2008120098A3
(en )
2009-01-08
Peptide prodrugs
WO2010127099A3
(en )
2014-03-20
Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
WO2008067219A3
(en )
2008-07-17
Quinazolinone modulators of tgr5
WO2011133875A3
(en )
2012-03-08
Metalloenzyme inhibitor compounds
WO2009002423A3
(en )
2009-04-23
Polycyclic guanine derivatives and use thereof
WO2011053825A3
(en )
2011-09-29
Compositions and methods for the treatment or prevention of mitochondrial diseases
WO2012125544A3
(en )
2013-02-28
Necroptosis inhibitors and methods of use therefor
WO2008149353A3
(en )
2010-02-25
Telomerase activating compounds and methods of use thereof
WO2011082245A3
(en )
2011-11-10
Metalloenzyme inhibitor compounds
WO2014151456A3
(en )
2014-12-18
Treatment of inflammatory diseases
WO2010014253A3
(en )
2010-04-29
Ant4 inhibitor compounds and methods of use thereof
BRPI0820440A2
(en )
2015-05-26
Aldh-2 inhibitors in the treatment of psychiatric disorders.
WO2009076359A3
(en )
2009-11-05
Modulators of neuronal regeneration
WO2012082862A3
(en )
2012-09-20
Androgen receptor inhibitors and methods of use thereof
WO2012058529A3
(en )
2012-07-19
Metalloenzyme inhibitor compounds
WO2009053683A3
(en )
2009-06-25
Treatment of inflammatory diseases
WO2010077310A3
(en )
2010-11-04
Amide derivatives of ethacrynic acid
WO2011014520A3
(en )
2011-06-23
Compounds and compositions as modulators of gpr119 activity